Blinatumomab (trade name Blincyto, previously known as AMG103) is a drug used to treat Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
Blinatumomab (trade name Blincyto, previously known as AMG103) is a drug that has anti-cancer properties. Blinatumomab is used to treat Philadelphia chromosome-negative relapsed or refractory Bcell precursor acute lymphoblastic leukemia.